» Articles » PMID: 34649875

Hemiplegic Migraine Associated With Variations: A Clinical and Genetic Study

Abstract

Background And Objective: variants have been reported in a few cases of patients with hemiplegic migraine. To clarify the role of in familial hemiplegic migraine, we studied this gene in a large cohort of affected probands.

Methods: was analyzed in 860 probands with hemiplegic migraine, and variations were identified in 30 probands. Genotyping of relatives identified a total of 49 persons with variations whose clinical manifestations were detailed.

Results: variations were found in 12 of 163 probands who previously tested negative for , , and variations and in 18 of 697 consecutive probands screened simultaneously on the 4 genes. In this second group, pathogenic variants were found in 105 individuals, mostly in (42%), followed by (26%), 17%), and (15%). The variations included 7 distinct variants, 5 of which have already been described in persons with paroxysmal kinesigenic dyskinesia and 2 new variants. Eight probands had a deletion of the whole gene. Among the 49 patients with variations in , 26 had pure hemiplegic migraine and 16 had hemiplegic migraine associated with another manifestation: epilepsy (8), learning disabilities (5), hypersomnia (4), or abnormal movement (3). Three patients had epilepsy without migraine: 2 had paroxysmal kinesigenic dyskinesia without migraine, and 1 was asymptomatic.

Discussion: should be regarded as the fourth autosomal dominant gene for hemiplegic migraine and screened in any affected patient, together with the 3 other main genes. Further studies are needed to understand how the same loss-of-function variations can lead to a wide range of neurologic phenotypes, including paroxysmal movement disorder, epilepsy, learning disabilities, sleep disorder, and hemiplegic migraine.

Citing Articles

The link between spreading depolarization and innate immunity in the central nervous system.

Soylu K, Yemisci M, Karatas H J Headache Pain. 2025; 26(1):25.

PMID: 39901107 PMC: 11792447. DOI: 10.1186/s10194-024-01938-5.


Hallmarks of primary headache: part 1 - migraine.

Raggi A, Leonardi M, Arruda M, Caponnetto V, Castaldo M, Coppola G J Headache Pain. 2024; 25(1):189.

PMID: 39482575 PMC: 11529271. DOI: 10.1186/s10194-024-01889-x.


Efficacy of galcanezumab in proline-rich transmembrane protein 2 (PRRT2)-associated familial hemiplegic migraine: A case series.

Sottani C, Di Lazzaro G, Calabresi P, Pomponi M, Tiziano F, Bentivoglio A Headache. 2024; 65(2):377-381.

PMID: 39345003 PMC: 11794975. DOI: 10.1111/head.14840.


Identification of Polymorphisms in EAAT1 Glutamate Transporter Gene Associated with Reduced Migraine Risk.

Albury C, Sutherland H, Lam A, Tran N, Lea R, Haupt L Genes (Basel). 2024; 15(6).

PMID: 38927733 PMC: 11202508. DOI: 10.3390/genes15060797.


Unravelling the Genetic Landscape of Hemiplegic Migraine: Exploring Innovative Strategies and Emerging Approaches.

Alfayyadh M, Maksemous N, Sutherland H, Lea R, Griffiths L Genes (Basel). 2024; 15(4).

PMID: 38674378 PMC: 11049430. DOI: 10.3390/genes15040443.